SCHEMBL2433685

SCHEMBL2433685

COC(=O)c1c(-c2ccc(F)cc2)oc2ncc(-c3cc(C(=O)N(c4ccccn4)C4CC4)ccc3Cl)cc12

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
TRPM8 Q7Z2W7 1/20 0.40
NPC1 O15118 1/20 0.37
KCNH2 Q12809 3/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C8 P10632 2/20 0.36
NR1I2 O75469 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.35
RORC P51449 3/20 0.35
OPRD1 P41143 1/20 0.35
PCSK9 Q8NBP7 1/20 0.35
ABL1 P00519 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2434818 0.92 ALDH1A1 (0.45) ALDH1A1TRPM8NPC1KCNH2CYP3A4
SCHEMBL2437777 0.92 ALDH1A1 (0.45) ALDH1A1TRPM8KCNH2CYP3A4CYP2C8
SCHEMBL1937242 0.91 ALDH1A1 (0.47) ALDH1A1TRPM8NPC1KCNH2CYP3A4
SCHEMBL1935138 0.84 ALDH1A1 (0.47) ALDH1A1TRPM8NPC1KCNH2CYP3A4
SCHEMBL1936381 0.84 CYP2C8 (0.53) ALDH1A1TRPM8KCNH2CYP3A4CYP2C8
SCHEMBL1919040 0.81 CYP2C8 (0.55) ALDH1A1KCNH2CYP3A4CYP2C8NR1I2
SCHEMBL1936685 0.81 RCE1 (0.41) ABL1
SCHEMBL1936612 0.79 CYP2C8 (0.58) KCNH2CYP3A4CYP2C8NR1I2ABL1
SCHEMBL1936895 0.76 CYP2C8 (0.54) KCNH2CYP3A4CYP2C8NR1I2ABL1
SCHEMBL1918701 0.75 CYP2C8 (0.54) ALDH1A1TRPM8KCNH2CYP3A4CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545050-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112186-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed